From February 25, 2022 to March 7, 2022, the company has repurchased 40,323 shares, representing 0.23% for KRW 547.51 million. With this, the company has completed the repurchase of 40,323 shares, representing 0.23% for KRW 547.51 million under the buyback announced on February 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,065 KRW | -1.67% | -1.67% | -1.20% |
1st Jan change | Capi. | |
---|---|---|
-1.20% | 58.1M | |
-2.53% | 254B | |
-2.48% | 17.54B | |
-2.87% | 10.82B | |
-4.71% | 10.58B | |
-16.41% | 5.56B | |
-6.14% | 5.1B | |
+6.63% | 5.05B | |
+3.37% | 3.85B | |
-12.75% | 3.49B |
- Stock
- Equities
- Stock Icure Pharmaceutical Incorporation - Korea S.E.
- News Icure Pharmaceutical Incorporation
- Tranche Update on Icure Pharmaceutical Incorporation's Equity Buyback Plan announced on February 25, 2022.